Aromasin and Bone
Links shared publicly online about this topic
Pfizer’s Breast-Cancer Drug Worsens Bone Loss in Older Women - Businessweek
businessweek.com — “Pfizer Inc.’s breast-cancer drug Aromasin worsened bone loss in post-menopausal women, raising the chance of fractures and calling into question whether the pill’s prevention benefits outweigh its risks.” View full resource at businessweek.com
Most Recently Shared on February 11, 2012 at 12:18 am By:
Pfizer’s Breast-Cancer Drug Worsens Bone Loss in Older Women: Pfizer Inc.’s breast-cancer drug Aromasin worsened... http://t.co/Cg0ABRiX
Breast Cancer Drug Exemestane Causes Substantial Bone Loss
medicalnewstoday.com — “A recent study published in The Lancet Oncology shows how exemestane (Aromasin), a drug that prevents the development of breast cancer in postmenopausal women, may significantly worsen age-” View full resource at medicalnewstoday.com
Most Recently Shared on February 7, 2012 at 2:05 am By:
MNT Bones/Orthopedic Health News
Breast Cancer Drug Exemestane Causes Substantial Bone Loss http://t.co/ecLZ8ktZ #bones #orthopedics
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Bone Cancer OW
Organizing bone cancer resources shared by health experts, advocates, and organizations into WisdomCards.
-
MNT Bones/Orthopedic
The latest bones / orthopedics news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
